BioXcel Therapeutics, Inc. (BTAI)

1.48 -0.13 (-8.07%) USD  |  NASDAQ  |  Mar 06, 16:00
1.41 -0.07 (-4.73%) Pre-Market: 08:18
More

BioXcel Therapeutics Preferred Stock Dividend (% of Annual Revenues)

Preferred Stock Dividend (% of Annual Revenues) Chart

View Preferred Stock Dividend (% of Annual Revenues) for BTAI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Preferred Stock Dividend (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Preferred Stock Dividend (% of Annual Revenues) Range, Past 5 Years

View Preferred Stock Dividend (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Preferred Stock Dividend (% of Annual Revenues) Benchmarks

View Preferred Stock Dividend (% of Annual Revenues) Benchmarks
Start Trial
Rigel Pharmaceuticals, Inc. Upgrade
Puma Biotechnology, Inc. Upgrade
Quince Therapeutics, Inc. --
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade